DBV Technologies S.A.

DBVT · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $1.2B · 125 employees
321
SEC Filings
$11.43
Close 2026-11-12
125
Employees

Business Summary

DBV Technologies is a late-stage specialty biopharmaceutical company developing Viaskin, an epicutaneous immunotherapy (EPIT) platform that delivers allergens through intact skin via adhesive patches. Its lead product, Viaskin Peanut Patch, is in Phase 3 development for children ages 1-7 with peanut allergy, with BLA submissions planned for 2026. The company also has earlier-stage programs in Viaskin Milk for cow's milk allergy and eosinophilic esophagitis.

Latest Stock Quote

DBVT 2026-11-12 $11.43 O:$11.75 H:$11.93 L:$11.22 Vol:0.3M VWAP:$11.5479
origin leaf: null

Next Earnings

expected 2026-12-30

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-262025-12-310001628280-26-021504EDGAR99K words
2025-04-112024-12-310001613780-25-000006EDGAR99K words
2024-03-072023-12-310001193125-24-062357EDGAR109K words
2023-03-022022-12-310001193125-23-058309EDGAR106K words
2022-03-092021-12-310001193125-22-070467EDGAR99K words
2021-03-172020-12-310001193125-21-084223EDGAR99K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-10-282026-09-300001628280-26-067930EDGAR22K words
2026-07-162026-06-300001628280-26-048453EDGAR19K words
2025-10-282025-09-300001628280-25-046809EDGAR22K words
2025-07-292025-06-300001613780-25-000016EDGAR20K words
2025-04-302025-03-310001613780-25-000011EDGAR17K words
2024-11-062024-09-300001613780-24-000007EDGAR18K words
2024-07-302024-06-300001193125-24-188853EDGAR21K words
2024-05-072024-03-310001193125-24-133228EDGAR18K words
2023-10-312023-09-300001193125-23-267271EDGAR23K words
2023-07-312023-06-300001193125-23-199175EDGAR22K words
2023-05-042023-03-310001193125-23-136030EDGAR17K words
2022-11-032022-09-300001193125-22-277052EDGAR26K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-10-280001193125-26-436411EDGAR3K words
2026-09-300001193125-26-408052EDGAR1K words
2026-07-160001193125-26-306222EDGAR3K words
2026-03-260001193125-26-126671EDGAR2K words
2026-03-020001193125-26-084251EDGAR2K words
2026-01-200001193125-26-015592EDGAR3K words
2025-12-160001193125-25-320901EDGAR2K words
2025-10-300001193125-25-258780EDGAR1K words
2025-10-290001193125-25-253968EDGAR3K words
2025-09-180001193125-25-207507EDGAR0K words

321 total filings indexed. 293 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

peanut-allergy-treatment-(pediatric) cow's-milk-allergy-treatment-(pediatric) eosinophilic-esophagitis-treatment food-allergy-immunotherapy specialty-biopharmaceuticals epicutaneous-immunotherapy-(epit) breakthrough-therapy-designation-(fda) fast-track-designation-(fda) bla-(biologics-license-application)-regulatory-pathway

Company Identity

CIK0001613780
TickerDBVT
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedI0
Websitehttps://www.dbv-technologies.com
Listed2014-10-22

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 951e317eab42c80947f554cbbd26b3fb226f324e2caa0b0d4945dca1c3f7c60e
parent: ce54418bcdaa353c245ba3132ec4d27d81322c26d35c7b377dca812a29e5ea07
content hash: 548fc8aa23dd7f202b90861686765195ad33cbd5d2db619fc7fffb2351a5c464
signed: 2026-11-16T19:01:38.773Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up DBVT using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on DBVT, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/DBVT (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.